Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. PYLCLARI ((18F) piflufolastat)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

PYLCLARI ((18F) piflufolastat)

Medicine - Posted on May 31 2024 - Updated on May 31 2024
Active substance (DCI)
  • (18F) piflufolastat
history (2)
  • 11/16/23

    PYLCLARI ((18F) piflufolastat) - Cancer de la prostate

    Autorisation d’accès précoce octroyée à la spécialité PYLCLARI ((18F) piflufolastat) dans l’indication « Ce médicament est d...
    icône flèche
  • 2/28/24

    PYLCLARI ((18F) piflufolastat) - Prostate cancer (PCa)

    Summary of opinion Favourable opinion for reimbursement in the MA indication: “This medicinal product is for diagnostic use ...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • V09IX16
Manufacturer
CURIUM PET FRANCE
Presentation

PYLCLARI 1000 MBq/mL, solution injectable
Flacon multidose de 15 mL (CIP : 34009 550 974 3 3)

PYLCLARI 1500 MBq/mL, solution injectable
Flacon multidose de 15 mL (CIP : 34009 550 974 4 0)

All our publications
    Drug therapy Genital cancers Male genital diseases Medical imaging

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
NdgrrYCSbmNZpJB5